+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Advances across Oncology - Genetic Technology TOE

  • ID: 4012939
  • Report
  • November 2016
  • Region: Global
  • 15 pages
  • Frost & Sullivan
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now
This edition of Genetic Technology TOE profiles trends across oncology. Clinical trials related to gene editing and immunotherapies are illustrated in the study. The corresponding patent scenario is depicted along with the industry interactions.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Note: Product cover images may vary from those shown
2 of 2
Technology Profiles
  • First-in-human Clinical Trials for Gene-editing Platform
  • Microbiome-based Analyses for Immuno-Oncology
  • Global Academic Network for Cancer Immunotherapy
  • Cooperative R&
Appendix
  • Patent Scenario - Gene Therapy Technologies
  • Industry Interactions
Note: Product cover images may vary from those shown
Adroll
adroll